-mangostin promotes in vitro and in vivo degradation of androgen receptor and ar-v7 splice variant in prostate cancer cells

HIGHLIGHTS

• who: Mirielle C. Nauman and colleagues from the Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA have published the paper: -Mangostin Promotes In Vitro and In Vivo Degradation of Androgen Receptor and AR-V7 Splice Variant in Prostate Cancer Cells, in the Journal: Cancers 2023, 15, 2118. of /2023/
• what: This study evaluated for its novel ability to degrade the androgen receptor and androgen receptor variants. is one of more than 70 isoprenylated xanthones isolated from that the authors have been evaluating for their anticancer potential. The study . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.